These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 24517434)
1. Desensitization for solid organ and hematopoietic stem cell transplantation. Zachary AA; Leffell MS Immunol Rev; 2014 Mar; 258(1):183-207. PubMed ID: 24517434 [TBL] [Abstract][Full Text] [Related]
2. HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers. Joher N; Matignon M; Grimbert P Front Immunol; 2021; 12():688301. PubMed ID: 34093594 [TBL] [Abstract][Full Text] [Related]
3. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin. Yuan XP; Wang CX; Gao W; Fu Q; He XS Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369 [TBL] [Abstract][Full Text] [Related]
4. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience. Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614 [TBL] [Abstract][Full Text] [Related]
5. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation. Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP Clin Transpl; 2014; ():245-50. PubMed ID: 26281152 [TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Overview of the Clinical Relevance and Treatment Options for Antibody-mediated Rejection Associated With Non-HLA Antibodies. Kardol-Hoefnagel T; Otten HG Transplantation; 2021 Jul; 105(7):1459-1470. PubMed ID: 33208690 [TBL] [Abstract][Full Text] [Related]
7. Annual literature review of donor-specific HLA antibodies after organ transplantation. Kaneku H Clin Transpl; 2011; ():311-8. PubMed ID: 22755424 [TBL] [Abstract][Full Text] [Related]
8. The presence of donor-specific antibodies in renal transplantation. Tozkir H; Sağiroğlu T; Kiliçarslan-Ayna T; Tan S; Çopuroğlu E; Sağiroğlu G; Sari G; Gürkan H; Sezer A Transplant Proc; 2012; 44(6):1667-9. PubMed ID: 22841240 [TBL] [Abstract][Full Text] [Related]
9. Recent developments in desensitization of crossmatch-positive kidney transplant recipients. Morath C; Opelz G; Zeier M; Süsal C Transplant Proc; 2012; 44(6):1648-51. PubMed ID: 22841236 [TBL] [Abstract][Full Text] [Related]
10. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients. Everly MJ Clin Transpl; 2011; ():319-25. PubMed ID: 22755425 [TBL] [Abstract][Full Text] [Related]
11. Effects of Two Preemptive Post-transplant Desensitization Regimens Upon Renal Allograft Survival and DSA Elaboration. Kimball PM; McDougan FA; King A Clin Transpl; 2014; ():197-203. PubMed ID: 26281145 [TBL] [Abstract][Full Text] [Related]
12. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation. Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238 [TBL] [Abstract][Full Text] [Related]
13. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation. Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M; Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951 [TBL] [Abstract][Full Text] [Related]
15. The role of the histocompatibility laboratory in desensitization for transplantation. Leffell MS; Zachary AA Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates. Rostaing L; Congy N; Aarnink A; Maggioni S; Allal A; Sallusto F; Game X; Kamar N Exp Clin Transplant; 2015 Apr; 13 Suppl 1():201-6. PubMed ID: 25894155 [TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch. Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670 [TBL] [Abstract][Full Text] [Related]
18. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization. Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792 [TBL] [Abstract][Full Text] [Related]